Location History:
- Tarrytown, NY (US) (2019 - 2022)
- Ardsley, NY (US) (2017 - 2024)
Company Filing History:
10 out of 1,343 
3 out of 37 
Years Active: 2017-2024
Title: The Innovative Contributions of Robert C. Pordy
Introduction
Robert C. Pordy is a notable inventor based in Ardsley, NY, who has made significant contributions to the fields of biotechnology and pharmaceutical sciences. With a remarkable portfolio of 10 patents, Pordy has focused his work on advancing methods that enhance health and wellness through innovative scientific research and applications.
Latest Patents
Pordy's most recent patents demonstrate his commitment to addressing critical health issues. One patent pertains to "Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody." This invention provides various compositions, kits, and methodologies utilizing a GDF-8 inhibitor to promote increased lean muscle mass. In particular, it involves administering an effective amount of a GDF-8 inhibitor alongside a tailored exercise program.
Another of his latest patents is "Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab." This invention outlines strategies to diminish or completely remove the necessity of lipoprotein apheresis therapy through the administration of a pharmaceutical composition that includes a PCSK9 inhibitor, such as an anti-PCSK9 antibody. This method offers new hope for treating patients suffering from hyperlipidemia and related conditions.
Career Highlights
Throughout his career, Robert C. Pordy has collaborated with leading companies in the pharmaceutical industry, including Regeneron Pharmaceuticals and Sanofi Biotechnology. His work in these organizations has facilitated the development of groundbreaking healthcare solutions that address both common and complex medical conditions.
Collaborations
Pordy has had the opportunity to work alongside distinguished professionals in his field, including William J. Sasiela and Marie Baccara-Dinet. These collaborations have greatly contributed to his success and the advancement of innovative therapies and interventions.
Conclusion
Robert C. Pordy's dedication to research and innovation has led to significant advancements in healthcare. His patents reflect a profound commitment to improving patient outcomes through scientific ingenuity. As he continues to develop new concepts and solutions, his work will undoubtedly pave the way for further innovations in the biopharmaceutical industry.